PAPER Kanoh T, Mizoguchi T, Tonoki A, Itoh M
SEARCH RESULTS
332324 RESULTS
PAPER Kishida H, Kobayashi A, Teruya K, Doi H, Ueda N, Tanaka F, Kuroiwa Y, Parchi P, Mohri S, Kitamoto T
Transmission experiments verify sporadic V2 prion in a patient with E200K mutation.
Acta Neuropathol. 2024 May 20;147(1):89. PubMed.PAPER Hu Z, Yang J, Zhang S, Li M, Zuo C, Mao C, Zhang Z, Tang M, Shi C, Xu Y
AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 mice.
Neural Regen Res. 2025 Jan 1;20(1):253-264. Epub 2024 Mar 1 PubMed.PAPER Azargoonjahromi A
Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline.
J Pharm Pharmacol. 2024 May 20; PubMed.PAPER Hassanzadeh R, Abrol A, Pearlson G, Turner JA, Calhoun VD
A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.
PLoS One. 2024;19(5):e0293053. Epub 2024 May 20 PubMed.PAPER Canovai A, Williams PA
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism.
Neural Regen Res. 2025 Jan 1;20(1):41-53. Epub 2024 Apr 3 PubMed.PAPER Zhong R, Gan C, Sun H, Zhang K
Sleep disturbances, cognitive decline, and AD biomarkers alterations in early Parkinson's disease.
Ann Clin Transl Neurol. 2024 May 19; PubMed.PAPER Miao Y, Wolfe MS
Emerging structures and dynamic mechanisms of γ-secretase for Alzheimer's disease.
Neural Regen Res. 2025 Jan 1;20(1):174-180. Epub 2024 Mar 1 PubMed.PAPER Tedeschi V, Sapienza S, Ciancio R, Canzoniero LM, Pannaccione A, Secondo A
Lysosomal Channels as New Molecular Targets in the Pharmacological Therapy of Neurodegenerative Diseases via Autophagy Regulation.
Curr Neuropharmacol. 2024 May 17; PubMed.PAPER Qin H, Shi X, Zhu Y, Ma J, Deng X, Wang L
Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network.
Eur J Neurosci. 2024 May 19; PubMed.PAPER Li JZ, Ramalingam N, Li S
Targeting epigenetic mechanisms in amyloid-β-mediated Alzheimer's pathophysiology: unveiling therapeutic potential.
Neural Regen Res. 2025 Jan 1;20(1):54-66. Epub 2024 Mar 1 PubMed.PAPER Rhodius-Meester HF, van Maurik IS, Collij LE, van Gils AM, Koikkalainen J, Tolonen A, Pijnenburg YA, Berkhof J, Barkhof F, van de Giessen E, Lötjönen J, van der Flier WM
Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.
PLoS One. 2024;19(5):e0303111. Epub 2024 May 20 PubMed.PAPER Grenier A, O'Connor D, James K, Imahori D, Minchopoulos D, Velev N, Tamblyn-Watts L, Mann J
Consent and Inclusion of People Living with Dementia (PLWD) in Research: Establishing a Canadian Agenda for Inclusive Rights-Based Practices.
Can J Aging. 2024 May 20;:1-8. PubMed.PAPER Singh K, Gupta JK, Jain D, Kumar S, Saha S, Sharma A
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders.
Curr Pharm Biotechnol. 2024 May 17; PubMed.PAPER Zhao XY, Xu DE, Wu ML, Liu JC, Shi ZL, Ma QH